Sign up
Pharma Capital

THC Global obtains manufacturing licence for Southport cannabis facility

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris talks to Proactive Investors about receiving a medicinal cannabis manufacturing licence at its large Southport manufacturing facility on Queensland's Gold Coast.

The licence is required for the commercial production of medicinal cannabis products as well as undertaking a larger research and development (R&D) program.

“This is a major event for the medical cannabis sector in Australia and allows for formulation of a new generation of medicine,” he says.

 

View full THC profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.